The wire › SEC Form 8-K
Y-mAbs Therapeutics, Inc. YMAB
Filed with the SEC on Sep 16, 2025. Reported event date Sep 16, 2025.
- Business address
- Princeton, NJ
- State
- New Jersey
- Incorporated in
- Delaware
- Industry
- Manufacturing (SIC 2834)
- SEC CIK
- 1722964
- Accession number
- 0001104659-25-090232
Items reported in this filing
- Item 2.01 Completion of Acquisition or Disposition of Assets
- Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
An exchange told the company it does not meet a continued-listing rule, or the company is delisting or moving its listing: Form 8-K Item 3.01. Many of these are compliance notices with time to fix, not closures.
- Item 3.03 Material Modification to Rights of Security Holders
- Item 5.01 Changes in Control of Registrant
- Item 5.02 Departure or Appointment of Directors or Officers; Compensatory Arrangements
- Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
- Item 9.01 Financial Statements and Exhibits
Other entries on the wire for this company
Wire Pass $1.95/month or $19.50/year lets you watch up to 100 companies like this one. Free during preview See pricing